Surface display of Gaussia princeps luciferase allows sensitive fungal pathogen detection during cutaneous

Stefanie Donat1, Mike Hasenberg, Tina Schäfer

  • 1Institute of Molecular Infection Biology, Julius Maxilimilans University, Würzburg, Germany.

Virulence
|January 31, 2012
PubMed

Insights

A new bioluminescent Aspergillus fumigatus strain allows sensitive, non-invasive tracking of fungal infections in real-time. This tool aids in studying infection dynamics and evaluating antifungal therapies in mouse models.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Biotechnology

Background:

  • Non-invasive imaging is crucial for understanding pathogen-host interactions in microbial diseases.
  • Aspergillus fumigatus is a significant fungal pathogen, particularly in immunocompromised individuals.

Purpose of the Study:

  • To evaluate and validate a transgenic bioluminescence reporter strain of Aspergillus fumigatus.
  • To enable sensitive, spatio-temporal monitoring of fungal infections and antifungal therapy.

Main Methods:

  • Development of a transgenic Aspergillus fumigatus strain expressing Gaussia princeps luciferase.
  • Utilizing bioluminescence detection for quantifying fungal burden in a cutaneous aspergillosis mouse model.
  • Monitoring infection progression and response to antifungal treatment.

Main Results:

  • The reporter strain exhibited sensitive and rapid luminescence detection, correlating with fungal conidia and germling amounts.
  • Spatio-temporal monitoring of infection was achieved in both neutropenic and immunocompetent mice.
  • The strain facilitated the tracking of antifungal therapy efficacy in the disease model.

Conclusions:

  • The bioluminescent reporter strain enables longitudinal studies of cutaneous aspergillosis.
  • This approach offers a sensitive tool for high-throughput drug screening and antifungal therapy evaluation.

Related Concept Videos